User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 14 results.
    • Journal article
    A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
    Farmer, Pierre Bonnefoi, Herve[UCL] Anderle, Pascale Cameron, David Wirapati, Pratyakasha Becette, Veronique Andre, Sylvie Piccart, Martine Campone, Mario Brain, Etienne MacGrogan, Gaetan Petit, Thierry Jassem, Jacek Bibeau, Frederic Blot, Emmanuel Bogaerts, Jan[UCL] Aguet, Michel Bergh, Jonas Iggo, Richard Delorenzi, Mauro (2009) Nature Medicine — Vol. 15, no. 1, p. 68-74 (2009)
    • Journal article
    Oncological care organisation during COVID-19 outbreak
    Onesti, Concetta Elisa Rugo, Hope S. Generali, Daniele Peeters, Marc Zaman, Khalil Wildiers, Hans Harbeck, Nadia Martin, Miguel Cristofanilli, Massimo Cortes, Javier Tjan-Heijnen, Vivianne Hurvitz, Sara A. Berchem, Guy Tagliamento, Marco Campone, Mario Bartsch, Rupert De Placido, Sabino Puglisi, Fabio Rottey, Sylvie Müller, Volkmar Ruhstaller, Thomas Machiels, Jean-Pascal[UCL] Conte, PierFranco Awada, Ahmad Jerusalem, Guy (2020) ESMO Open — Vol. 5, no. 4, p. e000853 [1-8] (2020)
    • Journal article
    UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer.
    Campone, Mario Lacroix-Triki, Magali Roca, Lise Spielmann, Marc Wildiers, Hans Cottu, Paul Kerbrat, Pierre Levy, Christelle Desmoulins, Isabelle Bachelot, Thomas Winston, Tan Eymard, Jean-Christophe Uwer, Lionel Duhoux, François[UCL] Verhoeven, Didier Jaubert, Dominique Coeffic, David Orfeuvre, Hubert Canon, Jean Luc Asselain, Bernard Martin, Anne-Laure Lemonnier, Jerome Roché, Henri (2018) European journal of cancer — Vol. 103, p. 184-194 (2018)
    • Journal article
    Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations.
    Hyman, David M Tran, Ben Paz-Ares, Luis Machiels, Jean-Pascal[UCL] Schellens, Jan H Bedard, Philippe L Campone, Mario Cassier, Philippe A Sarantopoulos, John Vaishampayan, Ulka Chugh, Rashmi Mahipal, Amit Lockhart, A Craig Sessa, Cristiana Zander, Thomas Ng, Matthew Curigliano, Giuseppe Bendiske, Jennifer Chen, Xueying Choudhury, Somesh Graus-Porta, Diana Lewis, Nancy Perez Garcia, Jose Manuel de Miguel-Luken, María José (2019) JCO precision oncology — Vol. 3, no.1, p. 1-13 (2019)
    • Journal article
    Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer
    Toffoli, Sébastien Bar, Isabelle Abdel-Sater, Fadi Delrée, Paul Hilbert, Pascale Cavallin, Frédéric Moreau, Fabrice Van Criekinge, Wim Lacroix-Triki, Magali Campone, Mario Martin, Anne-Laure Roché, Henri Machiels, Jean-Pascal[UCL] Carrasco, Javier[UCL] Canon, Jean-Luc (2014) Breast Cancer Research — Vol. 16, no.6, p. 466 (2014)
    • Journal article
    A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy
    Campone, Mario Berton-Rigaud, Dominique Joly-Lobbedez, Florence Baurain, Jean-François[UCL] Rolland, Frédéric Stenzl, Arnulf Fabbro, Michel van Dijk, Marjan Pinkert, Jörg Schmelter, Thomas de Bont, Natasja Pautier, Patricia (2013) The Oncologist — Vol. 18, no.11, p. 1190-1191 (2013)
    • Journal article
    A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
    Limentani, Steven A Campone, Mario Dorval, Thierry Curigliano, Giuseppe de Boer, Richard Vogel, Charles White, Shane Bachelot, Thomas Canon, Jean-Luc Disis, Mary Awada, Ahmad Berlière, Martine[UCL] Amant, Frédéric Levine, Ellis Burny, Wivine Callegaro, Andrea de Sousa Alves, Pedro Miguel Louahed, Jamila Brichard, Vincent Lehmann, Frédéric F (2016) Breast Cancer Research and Treatment — Vol. 156, no.2, p. 319-330 (2016)
    • Journal article
    A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer.
    Kuemmel, Sherko Campone, Mario Loirat, Delphine Lopez, Rafael Lopez Beck, J Thaddeus De Laurentiis, Michelino Im, Seock-Ah Kim, Sung-Bae Kwong, Ava Steger, Guenther G Adelantado, Esther Zamora Duhoux, François[UCL] Greil, Richard Kuter, Irene Lu, Yen-Shen Tibau, Ariadna Özgüroğlu, Mustafa Scholz, Christian W Singer, Christian F Vega, Estela Wimberger, Pauline Zamagni, Claudio Couillebault, Xuan-Mai Fan, Liqiong Guerreiro, Nelson Mataraza, Jennifer Sand-Dejmek, Janna Chan, Arlene (2022) Clinical cancer research — Vol. 28, no. 1, p. 106-115 (2022)
    • Journal article
    Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma : EORTC brain tumor group study 26034
    van den Bent, Martin J. Baurain, Jean-François[UCL] Brandes, Alba A. Rampling, Roy Kouwenhoven, Mathilde C. M. Kros, Johan M. Carpentier, Antoine F. Clement, Paul M. Campone, Mario Armand, Jean-Paul Taphoorn, Martin J. B. Tosoni, Alicia Kletzl, Heidemarie Klughammer, Barbara Lacombe, Denis Gorlia, Thierry (2009) Journal of Clinical Oncology — Vol. 27, no. 8, p. 1268-1274 (2009)
    • Journal article
    Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial
    Coudert, Bruno Asselain, Bernard Campone, Mario Spielmann, Marc Machiels, Jean-Pascal[UCL] Pénault-Llorca, Frédérique Serin, Daniel Lévy, Christelle Romieu, Gilles Canon, Jean-Luc Orfeuvre, Hubert Piot, Gilles Petit, Thierry Jerusalem, Guy Audhuy, Bruno Veyret, Corinne Beauduin, Marc Eymard, Jean-Christophe Martin, Anne-Laure Roché, Henri the UNICANCER Breast Group (2012) The Oncologist — Vol. 17, no.7, p. 900-909 (2012)
    • Journal article
    A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer
    Mayer, Erica L Baurain, Jean-François[UCL] Sparano, Joseph Strauss, Lewis Campone, Mario Fumoleau, Pierre Rugo, Hope Awada, Ahmad Sy, Oumar Llombart-Cussac, Antonio (2011) Clinical Cancer Research — Vol. 17, no.21, p. 6897-6904 (2011)
    • Journal article
    Trastuzumab for patients with axillary-node-positive breast cancer : results of the FNCLCC-PACS 04 trial
    Spielmann, Marc Roché, Henri Delozier, Thierry Canon, Jean-Luc Romieu, Gilles Bourgeois, Hugues Extra, Jean-Marc Serin, Daniel Kerbrat, Pierre Machiels, Jean-Pascal[UCL] Lortholary, Alain Orfeuvre, Hubert Campone, Mario Hardy-Bessard, Anne-Claire Coudert, Bruno Maerevoet, Marie Piot, Gilles Kramar, Andrew Martin, Anne-Laure Penault-Llorca, Frédérique (2009) Journal of Clinical Oncology — Vol. 27, no. 36, p. 6129-6134 (2009)
    • Speech
    Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: The FNCLCC PACS 01 trial
    Roche, Henri Fumoleau, Pierre Spielmann, Marc Canon, Jean-Luc Delozier, Thierry Serin, Daniel Symann, Michel[UCL] Kerbrat, Pierre Soulie, Patrick Eichler, Francoise Viens, Patrice Monnier, Alain Vindevoghel, Anita Campone, Mario Goudier, Marie-Josephe Bonneterre, Jacques Ferrero, Jean-Marc Martin, Anne-Laure Geneve, Jean Asselain, Bernard (2006) 27th Annual San Antonio Breast Cancer Symposium — San Antonio (Tx)
    • Journal article
    Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Baselga, José Im, Seock-Ah Iwata, Hiroji Cortés, Javier De Laurentiis, Michele Jiang, Zefei Arteaga, Carlos L Jonat, Walter Clemons, Mark Ito, Yoshinori Awada, Ahmad Chia, Stephen Jagiełło-Gruszfeld, Agnieszka Pistilli, Barbara Tseng, Ling-Ming Hurvitz, Sara Masuda, Norikazu Takahashi, Masato Vuylsteke, Peter[UCL] Hachemi, Soulef Dharan, Bharani Di Tomaso, Emmanuelle Urban, Patrick Massacesi, Cristian Campone, Mario (2017) The Lancet Oncology — Vol. 18, no.7, p. 904-916 (2017)